SecBot SecBot
EFFECT ·Filed Feb 27, 2026

RXST

RxSight, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed8mo ago SEC9999999995-26-000671
IPO/offering going effective
Actionable Insight • Neutral

Traders should monitor for future prospectus supplements that will disclose specific offering terms, timing, and size. The mere effectiveness of a shelf registration often creates a mild overhang but is not an immediate signal of dilution.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
RXST ▼ -19.92% at T+60d
NEUTRAL call -19.92% · α vs SPY -29.31% · entry $7.48 → $5.99
Entry = T+0 close
Feb 27, 2026
via day close
T+1d
+1.74%
call +1.74% · α +1.68%
$7.61
settled 8mo ago
T+5d
+2.81%
call +2.81% · α +4.79%
$7.69
settled 8mo ago
T+20d
-16.31%
call -16.31% · α -8.75%
$6.26
settled 7mo ago
T+60d
-19.92%
call -19.92% · α -29.31%
$5.99
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

RxSight, Inc. (RXST) has announced the effectiveness of its SEC Form S-3 shelf registration (File No. 333-279206), allowing the company to issue unspecified securities from time to time. This creates a potential for future dilution, though no specific offering size or securities are disclosed.

Key Facts

  • RxSight, Inc. (RXST) filed an EFFECT notice for registration statement 333-279206 on February 26, 2026.
  • The filing confirms the effectiveness of a shelf registration (Form S-3), enabling the company to offer and sell securities in the future.
  • No specific offering size, pricing, or type of securities (e.g., common stock, debt) is disclosed in the filing.
  • The company may now access capital markets at its discretion, subject to market conditions.

Financial Impact

Potential future dilution or debt issuance; magnitude unknown

dilutiondebtequity

Risk Factors

  • Future issuance of shares could lead to equity dilution and downward pressure on the stock price.
  • Market perception of the shelf as a sign of near-term capital raising could weigh on sentiment.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000671
Document: 9999999995-26-000671-index.html9999999995-26-000671
Document: 9999999995-26-000671.txt9999999995-26-000671
5 reports for RXST
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for RXST — sortable, filterable
TypeNow
Oct 20, 2026
6d ago
Press Release
NEUTRAL ★ 2/10
$4.90awaiting T+20—$5.02 (+2.45%)
Sep 2, 2026
7w ago
Insider Cluster
BEARISH ★ 4/10
$6.54 $4.68▲ +28.44%▲ +27.25%$5.02 (+23.24%)
Sep 2, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$6.54 $4.68▼ −28.44%▼ −27.25%$5.02 (−23.24%)
Apr 22, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$7.20 $6.16▼ −14.44%▼ −19.08%$5.02 (−30.28%)
Feb 27, 2026
34w ago
EFFECT
NEUTRAL ★ 4/10
$7.48 $6.26▼ −16.31%▼ −8.75%$5.02 (−32.89%)
Showing 5 of 5

US Market Status

Market Closed — Opens Wed (13h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 27, 2026